Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed May 15, 2019 · 10-Q · 45 days after period end · 0001193125-19-147291
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$976.06K | -$190.79K | -$3.96M | -$3.33M |
| EPS Diluted | -$0.14 | -$0.03 | -$0.15 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end
